Documentation
A certificate of analysis is generated for every batch and provided on request — ask with your order, or any time after. How we test →
- Reverse-phase HPLC — purity
- Mass spectrometry — identity and molecular weight confirmation
Tesamorelin 20 mg
A stabilised 44-residue GHRH analogue, supplied as a reference compound for growth hormone-releasing hormone receptor research.
No cart, no checkout, no card details. A request is reviewed by a person and answered by email with pricing and availability.
Specification
| Catalog number | RRL-TESA20 |
|---|---|
| Quantity | 20 mg per vial |
| Physical form | Lyophilised powder |
| CAS number | 218949-48-5 |
| Molecular formula | C₂₂₁H₃₆₆N₇₂O₆₇S |
| Molecular weight | ≈ 5135.9 g/mol |
| Solubility | Soluble in sterile water and bacteriostatic water for laboratory preparation. |
| Storage | Store lyophilised at −20 °C, protected from light. Once reconstituted, store at 2–8 °C and use within the period established by your protocol. |
Cited research context
- GHRH receptor pharmacology
- Growth hormone axis research models
- Comparative studies against shorter GRF fragments
Description
Tesamorelin is a synthetic analogue of human growth hormone-releasing hormone, retaining the full 44-residue sequence with a trans-3-hexenoyl group attached at the N-terminus. That modification distinguishes it structurally from unmodified GHRH and from the truncated 1-29 fragments.
Its formula and mass are listed in the specification above.
Reta Research supplies this material strictly as an analytical reference material for in-vitro and laboratory research. We do not provide protocols, preparation guidance, dosing information, or any instruction relating to administration, and we make no representation as to what this material does or is suitable for. Determining suitability for your application is your responsibility.
Other compounds
BPC-157
A synthetic 15-amino-acid peptide, supplied as an analytical reference material in two fills.
- Sizes
- 10 mg · 20 mg
- Form
- Lyophilised powder
Retatrutide
A synthetic triple receptor agonist peptide (GLP-1 / GIP / glucagon) studied in metabolic research models. Available in two fills.
- Sizes
- 10 mg · 40 mg
- Form
- Lyophilised powder
MOTS-c · 40 mg
RRL-MOTSC40A 16-residue mitochondrial-derived peptide encoded in mitochondrial DNA, used as a reference compound in metabolic and mitochondrial signalling research.
- Quantity
- 40 mg per vial
- Form
- Lyophilised powder